Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes
(Q28168585)
scientific article (publication date: May 2004)
scientific article (publication date: May 2004)
Language:
Current Data About
Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes
| (P31) |
(Q13442814)
|
||||||||||||||
| (P304) |
1610-5
|
||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||
| (P433) |
5
|
||||||||||||||
| (P478) |
125
|
||||||||||||||
| (P577) |
+2004-05-00T00:00:00Z
|
||||||||||||||
| (P921) |
(Q194908)
(Q266018)
|
||||||||||||||
| (P1433) |
(Q5093377)
|
||||||||||||||
| (P1476) |
"Rofecoxib, a COX-2 inhibitor, lowers C-reactive protein and interleukin-6 levels in patients with acute coronary syndromes" (language: en)
|
||||||||||||||
| (P2093) |
Daniel Monakier
Michal Mates
Marc W Klutstein
Jonathan A Balkin
Bernard Rudensky
David Meerkin
Dan Tzivoni
|
other details
| description | scientific article (publication date: May 2004) |
External Links
| (P356) |
10.1378/CHEST.125.5.1610
|
| (P698) |
15136366
|